FirsthandHealth
medRxiv PreprintsInternational20 November 2026

Amyotrophic lateral sclerosis progression is tracked in plasma by systemic proteins independent of motor neurons

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

Blood biomarkers that change as patients with amyotrophic lateral sclerosis (ALS) decline would allow progression to be monitored more objectively. Plasma proteomic studies have identified proteins that differ between patients and controls, but which plasma proteins change as patients decline, and whether they come from motor neurons, is unknown. Here, we leveraged the Answer ALS cohort, with serial SomaScan plasma proteomics, repeated ALS Functional Rating Scale-Revised assessments, and induced pluripotent stem cell-derived motor neurons (iMNs) from the same patients. At baseline, 77 plasma p
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.